Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Kanion Sunshine Pharmaceutical is a prominent subsidiary of the Jiangsu Kanion Pharmaceutical Group, specializing in the research, development, and manufacturing of modernized Traditional Chinese Medicine (TCM) and chemical drugs. Based in Lianyungang, China, the company focuses on high-growth therapeutic areas including cardiovascular health, gynecology, orthopedics, and respiratory diseases. Kanion Sunshine is recognized for its commitment to scientific rigor, utilizing advanced extraction and purification technologies to transform traditional herbal remedies into standardized pharmaceutical products. Its portfolio includes several blockbuster TCM products that are widely prescribed in Chinese hospitals for conditions such as uterine fibroids and ischemic stroke. The company plays a vital role in the parent group's strategy to integrate traditional medical wisdom with modern clinical evidence. With a strong emphasis on R&D, Kanion Sunshine continues to expand its pipeline with both innovative herbal formulations and high-quality chemical medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kanion Sunshine.